Switch From Nevirapine-based Regimen to Once a Day Rilpivirine/Emtricitabine/Tenofovir (Near- Rwanda)

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified April 2014 by Stanford University
Sponsor:
Collaborators:
Rwanda Biomedical Center
Gilead Sciences
Information provided by (Responsible Party):
Andrew Zolopa, Stanford University
ClinicalTrials.gov Identifier:
NCT02104700
First received: April 1, 2014
Last updated: NA
Last verified: April 2014
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: July 2015
  Estimated Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)